Full Press Release Details
Tenon Medical Expands Sacro-Pelvic Fusion
Portfolio with Strategic Asset Acquisition
~ SiVantage Portfolio Acquisition Enhances Tenon's
Sacroiliac Joint Fusion Capabilities with a Unique Multi-Product, Multi-Approach Solution ~
~ Significant Enhancement of Tenon Medical's
Commercial Leadership to Accelerate Growth Initiatives ~
~ Reinforces Tenon's Commitment to Fusion-Driven
Innovation and Data-Backed Outcomes in a Rapidly Evolving Market~
LOS GATOS, CA - August 1, 2025 -
Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical technology company dedicated to transforming
care for patients with sacroiliac joint (SIJ) disorders, today announced it has acquired sacroiliac (SI) joint specific assets from SiVantage,
a privately held startup company based in Tampa, Florida. This strategic asset acquisition includes SiVantage's SImmetry and
SImmetry+ technologies expanding Tenon's SI portfolio across multiple approaches to the variable sacro pelvic anatomy. These
differentiated technologies enable physicians to customize treatment plans for their patients using novel authentic fusion products backed
Transaction Highlights
Management Commentary
"The sacro pelvic fusion space is evolving
very quickly. As our physician customers define their needs, Tenon Medical will deliver innovative solutions backed by clinical data to
emerge as a leader in this high growth space." said Steve Foster, Chief Executive Officer of Tenon Medical. "With the addition
of extraordinary people and a pipeline of innovative solutions, Tenon is now a multi-product and multi-approach sacro-pelvic organization
that is poised for growth. We are laser focused on innovative solutions that deliver authentic fusion principals in a format with a strong
safety profile backed by biomechanical and clinical data."
Wyatt Geist, CEO and Co-Founder of SiVantage and
a recognized entrepreneur in the space with over one hundred patents to his name stated, "I am extremely excited to work with this
data driven team to deliver exciting innovative technologies. It became clear in our early discussions with Tenon that we shared visions
and values focused on collaborating with ethical partners to redefine sacroiliac fusion and deliver safe, effective solutions that enhance
patient outcomes and provide unparalleled surgical reproducibility."
Nate Grawey, President and Co-Founder of SiVantage
added, "Tenon's platform is THE perfect fit for SImmetry and the soon to be launched SImmetry+. This combined company will
offer a differentiated portfolio that physicians want, administrators approve and payors value."
About Tenon Medical, Inc.
Tenon Medical, Inc., a medical device company
formed in 2012, has developed The Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a
single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal
planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the
Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest
cortical bone. Since the national launch of the Catamaran SI Joint Fusion System in October 2022, Tenon is focused on three commercial
opportunities with its System in the SI Joint market which include: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI
Joint implants and 3) Augmenting spinal fusion. For more information, please visit www.tenonmed.com.
The Tenon Medical logo shown above, and Catamaran , PiSIF ,
CAT PiSIF , ETAD , Posterior Inferior Sacroiliac Fusion , CAT SIJ Fusion System , Catamaran SIJ Fusion System , Catamaran
Inferior Posterior Fusion System , Catamaran Transfixation Fusion System , Catamaran Transfixation Fusion Device , SImmetry
are registered trademarks of Tenon Medical, Inc. MAINSAILTM, and SImmetry+ are also trademarks of Tenon Medical, Inc.